Table 1.
Baseline characteristics of patients at their first malignancy (n = 1203)
| Characteristics | Number | Column N % | |
|---|---|---|---|
| Sex | Female | 543 | 45.14% |
| Male | 660 | 54.86% | |
| Age group | 0–19 years | 7 | 0.58% |
| 20–39 years | 55 | 4.57% | |
| 40–59 years | 333 | 27.68% | |
| 50–69 years | 709 | 58.94% | |
| 70 years–older | 99 | 8.23% | |
| Race (White, Black, other) | White | 1124 | 93.43% |
| Black | 34 | 2.83% | |
| Othera | 45 | 3.74% | |
| Marital status at diagnosis | Divorced | 59 | 4.90% |
| Married (including common law) | 806 | 67.00% | |
| Separated | 11 | 0.91% | |
| Single (never married) | 110 | 9.14% | |
| Unknown | 87 | 7.23% | |
| Widowed | 130 | 10.81% | |
| State | California | 232 | 19.29% |
| Connecticut | 187 | 15.54% | |
| Georgia | 71 | 5.90% | |
| Hawaii | 42 | 3.49% | |
| Iowa | 169 | 14.05% | |
| Michigan | 185 | 15.38% | |
| New Mexico | 54 | 4.49% | |
| Utah | 79 | 6.57% | |
| Washington | 184 | 15.30% | |
| AYA site/WHO 2008b | 1.2 Acute myeloid leukemia | 3 | 0.25% |
| 1.3 Chronic myeloid leukemia | 4 | 0.33% | |
| 1.4 Other and unspecified leukemia | 19 | 1.58% | |
| 2.1 Non-Hodgkin lymphoma | 83 | 6.90% | |
| 2.2 Hodgkin lymphoma | 4 | 0.33% | |
| 3.1.1 Specified low-grade astrocytic tumors | 1 | 0.08% | |
| 3.1.3 Astrocytoma, NOS | 2 | 0.17% | |
| 3.2 Other glioma | 2 | 0.17% | |
| 4.1 Osteosarcoma | 1 | 0.08% | |
| 4.2 Chondrosarcoma | 3 | 0.25% | |
| 5.1 Fibromatous neoplasms | 1 | 0.08% | |
| 5.3.1.1 Specified (excluding Kaposi sarcoma) | 8 | 0.67% | |
| 5.3.1.2 Kaposi sarcoma | 2 | 0.17% | |
| 6.1 Germ cell and trophoblastic neoplasms of gonads | 9 | 0.75% | |
| 7.1 Melanoma | 114 | 9.48% | |
| 7.2 Skin carcinomas | 6 | 0.50% | |
| 8.1 Thyroid carcinoma | 23 | 1.91% | |
| 8.2.1 Nasopharyngeal carcinoma | 1 | 0.08% | |
| 8.2.2 Other sites in lip, oral cavity, and pharynx | 37 | 3.08% | |
| 8.2.3 Nasal cav, mid ear, sinus, larynx, ill-def head/neck | 19 | 1.58% | |
| 8.3 Carcinoma of trachea, bronchus, and lung | 39 | 3.24% | |
| 8.4 Carcinoma of breast | 206 | 17.12% | |
| 8.5.1 Carcinoma of kidney | 17 | 1.41% | |
| 8.5.2 Carcinoma of bladder | 65 | 5.40% | |
| 8.5.3 Carcinoma of gonads | 14 | 1.16% | |
| 8.5.4 Carcinoma of cervix and uterus | 51 | 4.24% | |
| 8.5.5 Carc of oth and ill-def sites, geniourinary tract | 295 | 24.52% | |
| 8.6.1 Carcinoma of colon and rectum | 131 | 10.89% | |
| 8.6.2 Carcinoma of stomach | 7 | 0.58% | |
| 8.6.3 Carcinoma of liver and intrahepatic bile ducts | 3 | 0.25% | |
| 8.6.5 Carc oth and ill-def sites, gastrointestinal tract | 7 | 0.58% | |
| 8.7.2 Carcinoma of other and ill-defined sites, NOS | 9 | 0.75% | |
| 9.2.3 Myeloma, mast cell, misc. lymphoreticular neo, NOS | 9 | 0.75% | |
| 9.2.4 Other specified neoplasms, NOS | 5 | 0.42% | |
| 10 Unspecified Malignant Neoplasms | 3 | 0.25% | |
aIncludes Asians or Pacific Islanders, and Indian Americans/ Alaska natives
bThe classification scheme for tumors of adolescents and young adults (AYA)